Canadian Stock Trader

Category: News

News

  • Teck Announces Commencement of Consent Solicitation

    NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (the “Company”) announced today the commencement of consent solicitations (each, a “Consent Solicitation” and, together, the “Consent Solicitations”) relating to its outstanding U.S. $142,236,000 aggregate principal amount of 3.900% notes due July 15, 2030 (the “2030 Notes”), its outstanding U.S. $179,456,000 aggregate principal amount of 6.125% notes due October 1, 2035 (the “2035 Notes”), its outstanding U.S. $189,908,000 aggregate principal amount of 6.000% notes due August 15, 2040 (the “2040 Notes”), its outstanding U.S. $242,528,000 aggregate principal amount of 6.250% notes due July 15, 2041 (the “2041 Notes”), its outstanding U.S. $166,862,000 aggregate principal amount of 5.200% notes due March 1, 2042 (the “2042 Notes”), and its outstanding U.S. $107,958,000 aggregate principal amount of 5.400% notes due February 1, 2043 (the “2043 Notes” and, together with the 2030 Notes, the 2035 Notes, the 2040 Notes, the 2041 Notes and the 2042 Notes, the “Affected Notes” and, together with any other notes issued from time to time under each relevant indenture, the “Notes”).

    Originally published via Source Article.

  • Teck Announces Commencement of Consent Solicitation

    NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (the “Company”) announced today the commencement of consent solicitations (each, a “Consent Solicitation” and, together, the “Consent Solicitations”) relating to its outstanding U.S. $142,236,000 aggregate principal amount of 3.900% notes due July 15, 2030 (the “2030 Notes”), its outstanding U.S. $179,456,000 aggregate principal amount of 6.125% notes due October 1, 2035 (the “2035 Notes”), its outstanding U.S. $189,908,000 aggregate principal amount of 6.000% notes due August 15, 2040 (the “2040 Notes”), its outstanding U.S. $242,528,000 aggregate principal amount of 6.250% notes due July 15, 2041 (the “2041 Notes”), its outstanding U.S. $166,862,000 aggregate principal amount of 5.200% notes due March 1, 2042 (the “2042 Notes”), and its outstanding U.S. $107,958,000 aggregate principal amount of 5.400% notes due February 1, 2043 (the “2043 Notes” and, together with the 2030 Notes, the 2035 Notes, the 2040 Notes, the 2041 Notes and the 2042 Notes, the “Affected Notes” and, together with any other notes issued from time to time under each relevant indenture, the “Notes”).

    Originally published via Source Article.

  • POET Technologies Appoints Dr. Bardia Pezeshki and Jean F. Rankin to Board of Directors as Long-serving Director, Jean-Louis Malinge Resigns

    TORONTO, Aug. 03, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today announced the appointments of Dr. Bardia Pezeshki and Jean F. Rankin to its Board of Directors, effective August 1, 2026. The new directors will serve until the Company’s next annual meeting of shareholders or until their successors are duly elected or appointed. In addition, the Company accepted the resignation, for personal reasons, of Jean-Louis Malinge, who has served on the board of POET Technologies since 2017. Mr. Malinge’s resignation was effective August 1, 2026.

    Originally published via Source Article.

  • POET Technologies Appoints Dr. Bardia Pezeshki and Jean F. Rankin to Board of Directors as Long-serving Director, Jean-Louis Malinge Resigns

    TORONTO, Aug. 03, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today announced the appointments of Dr. Bardia Pezeshki and Jean F. Rankin to its Board of Directors, effective August 1, 2026. The new directors will serve until the Company’s next annual meeting of shareholders or until their successors are duly elected or appointed. In addition, the Company accepted the resignation, for personal reasons, of Jean-Louis Malinge, who has served on the board of POET Technologies since 2017. Mr. Malinge’s resignation was effective August 1, 2026.

    Originally published via Source Article.

  • POET Technologies Appoints Dr. Bardia Pezeshki and Jean F. Rankin to Board of Directors as Long-serving Director, Jean-Louis Malinge Resigns

    TORONTO, Aug. 03, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today announced the appointments of Dr. Bardia Pezeshki and Jean F. Rankin to its Board of Directors, effective August 1, 2026. The new directors will serve until the Company’s next annual meeting of shareholders or until their successors are duly elected or appointed. In addition, the Company accepted the resignation, for personal reasons, of Jean-Louis Malinge, who has served on the board of POET Technologies since 2017. Mr. Malinge’s resignation was effective August 1, 2026.

    Originally published via Source Article.

  • POET Technologies Appoints Dr. Bardia Pezeshki and Jean F. Rankin to Board of Directors as Long-serving Director, Jean-Louis Malinge Resigns

    TORONTO, Aug. 03, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today announced the appointments of Dr. Bardia Pezeshki and Jean F. Rankin to its Board of Directors, effective August 1, 2026. The new directors will serve until the Company’s next annual meeting of shareholders or until their successors are duly elected or appointed. In addition, the Company accepted the resignation, for personal reasons, of Jean-Louis Malinge, who has served on the board of POET Technologies since 2017. Mr. Malinge’s resignation was effective August 1, 2026.

    Originally published via Source Article.

  • Helus Pharma Appoints Michael Halstead as Chief Executive Officer

    Former President of Intra-Cellular Therapies, Inc. was instrumental in building and scaling the company, which was subsequently acquired by Johnson & Johnson

    Originally published via Source Article.

  • Helus Pharma Appoints Michael Halstead as Chief Executive Officer

    Former President of Intra-Cellular Therapies, Inc. was instrumental in building and scaling the company, which was subsequently acquired by Johnson & Johnson

    Originally published via Source Article.

  • Helus Pharma Appoints Michael Halstead as Chief Executive Officer

    Former President of Intra-Cellular Therapies, Inc. was instrumental in building and scaling the company, which was subsequently acquired by Johnson & Johnson

    Originally published via Source Article.

  • Bombardier to Showcase its Exquisite Challenger 3500 at LABACE 2026 as Part of Extensive Multi-City Latin American Tour

    MONTREAL, Aug. 03, 2026 (GLOBE NEWSWIRE) — Bombardier announced today its industry-leading Challenger 3500 will be on display at the Latin American Business Aviation Conference & Exhibition 2026 (LABACE) Aug. 4–6 at Campo de Marte Airport in São Paulo, revealing its impressive design and performance attributes for clients in region.

    Originally published via Source Article.